- Home
- PVL vs NTRB Comparison
PVL vs NTRB Comparison
Compare PVL & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PVL
- NTRB
- Stock Information
- Founded
- PVL 2011
- NTRB 2016
- Country
- PVL United States
- NTRB United States
- Employees
- PVL N/A
- NTRB N/A
- Industry
- PVL Oil & Gas Production
- NTRB Industrial Specialties
- Sector
- PVL Energy
- NTRB Health Care
- Exchange
- PVL Nasdaq
- NTRB Nasdaq
- Market Cap
- PVL 60.1M
- NTRB 71.8M
- IPO Year
- PVL N/A
- NTRB N/A
- Fundamental
- Price
- PVL $1.99
- NTRB $7.02
- Analyst Decision
- PVL
- NTRB Buy
- Analyst Count
- PVL 0
- NTRB 1
- Target Price
- PVL N/A
- NTRB $13.00
- AVG Volume (30 Days)
- PVL 64.3K
- NTRB 32.7K
- Earning Date
- PVL 01-01-0001
- NTRB 09-09-2025
- Dividend Yield
- PVL 9.55%
- NTRB N/A
- EPS Growth
- PVL N/A
- NTRB N/A
- EPS
- PVL 0.09
- NTRB N/A
- Revenue
- PVL $4,598,992.00
- NTRB $2,578,059.00
- Revenue This Year
- PVL N/A
- NTRB $560.75
- Revenue Next Year
- PVL N/A
- NTRB $588.39
- P/E Ratio
- PVL $21.48
- NTRB N/A
- Revenue Growth
- PVL 37.78
- NTRB 42.92
- 52 Week Low
- PVL $1.30
- NTRB $2.98
- 52 Week High
- PVL $2.04
- NTRB $9.42
- Technical
- Relative Strength Index (RSI)
- PVL 57.76
- NTRB 56.34
- Support Level
- PVL $1.98
- NTRB $5.85
- Resistance Level
- PVL $2.03
- NTRB $7.48
- Average True Range (ATR)
- PVL 0.04
- NTRB 0.45
- MACD
- PVL -0.00
- NTRB 0.13
- Stochastic Oscillator
- PVL 43.78
- NTRB 72.19
About PVL Permianville Royalty Trust Trust Units
Permianville Royalty Trust is a statutory trust which holds net profits interests in the profits from the sale of oil and natural gas production from non-operated assets of both conventional properties in the States of Texas, Louisiana, and New Mexico as well as unconventional assets in the Permian and Haynesville basins.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.